Infectious Immunology - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB509241236

Publication Date:

September 19, 2024

Pages:

129

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Infection involves an attack of disease-causing agents such as bacteria and viruses on the host organism鈥檚 body that causes disturbances in normal functioning. Immunology is the study of the human body鈥檚 resistance to these infections. The combined study of infections and immunology would help authorities to handle infectious disease conditions including HIV, hepatitis, pneumonia, tuberculosis, malaria, inflammatory bowel diseases and autoimmune diseases. The infectious immunology market comprises of the diagnosis and treatment of these infectious diseases with the help of antigen antibody reactions.
The global market for Infectious Immunology was estimated to be worth US$ 22160 million in 2023 and is forecast to a readjusted size of US$ 37790 million by 2030 with a CAGR of 7.9% during the forecast period 2024-2030
The global immunology market is gaining momentum due to the availability of various drugs approved by regulatory authorities and trends of improving clinical efficacy for new drug approvals. The high prevalence of immunological disorders further drives the market. The growing number of successful clinical trials due to environmental factors and the demand for biologics leads companies to invest in developing an affordable and effective imitation of biologic drugs and biosimilars. Furthermore, the ever-increasing cases of immunological diseases worldwide due to increasing geriatric populations and the adoption of sedentary lifestyles are pushing the market for growth. Additionally, the rising research and development activities in life sciences and biologics, including immunological drugs, will support market growth. Furthermore, the growing support from the governmental bodies and the approvals from the FDA for clinical trials are expected to enhance the market revenue from the governmental bodies and the approvals from the FDA for clinical trials are expected to enhance the market revenue.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Infectious Immunology, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Infectious Immunology by region & country, by Type, and by Application.
The Infectious Immunology market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Infectious Immunology.
麻豆原创 Segmentation
By Company
Abbott Laboratories
Roche Diagnostics
Thermo Fisher Scientifics
Bio-Rad Laboratories
Dr. Reddy鈥檚 Laboratories
AbbVie Inc
Janssen Global Services
Johnson & Johnson
Amgen Inc
Pfizer Inc
Novartis
Astellas
Bristol-Myers Squibb Company
Merck Sharp & Dohme Corp
UCB SA
Allergan
Segment by Type:
Diagnostic Kits
Instruments
Reagents
Segment by Application
HIV
TB
HBV and HCV
Pneumonia
Malaria
Inflammatory Bowel Diseases
Auto Immune Diseases
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Infectious Immunology manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Infectious Immunology in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Infectious Immunology in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Infectious Immunology Product Introduction
1.2 Global Infectious Immunology 麻豆原创 Size Forecast
1.3 Infectious Immunology 麻豆原创 Trends & Drivers
1.3.1 Infectious Immunology Industry Trends
1.3.2 Infectious Immunology 麻豆原创 Drivers & Opportunity
1.3.3 Infectious Immunology 麻豆原创 Challenges
1.3.4 Infectious Immunology 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Infectious Immunology Players Revenue Ranking (2023)
2.2 Global Infectious Immunology Revenue by Company (2019-2024)
2.3 Key Companies Infectious Immunology Manufacturing Base Distribution and Headquarters
2.4 Key Companies Infectious Immunology Product Offered
2.5 Key Companies Time to Begin Mass Production of Infectious Immunology
2.6 Infectious Immunology 麻豆原创 Competitive Analysis
2.6.1 Infectious Immunology 麻豆原创 Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Infectious Immunology Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Immunology as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Diagnostic Kits
3.1.2 Instruments
3.1.3 Reagents
3.2 Global Infectious Immunology Sales Value by Type
3.2.1 Global Infectious Immunology Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Infectious Immunology Sales Value, by Type (2019-2030)
3.2.3 Global Infectious Immunology Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 HIV
4.1.2 TB
4.1.3 HBV and HCV
4.1.4 Pneumonia
4.1.5 Malaria
4.1.6 Inflammatory Bowel Diseases
4.1.7 Auto Immune Diseases
4.1.8 Others
4.2 Global Infectious Immunology Sales Value by Application
4.2.1 Global Infectious Immunology Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Infectious Immunology Sales Value, by Application (2019-2030)
4.2.3 Global Infectious Immunology Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Infectious Immunology Sales Value by Region
5.1.1 Global Infectious Immunology Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Infectious Immunology Sales Value by Region (2019-2024)
5.1.3 Global Infectious Immunology Sales Value by Region (2025-2030)
5.1.4 Global Infectious Immunology Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Infectious Immunology Sales Value, 2019-2030
5.2.2 North America Infectious Immunology Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Infectious Immunology Sales Value, 2019-2030
5.3.2 Europe Infectious Immunology Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Infectious Immunology Sales Value, 2019-2030
5.4.2 Asia Pacific Infectious Immunology Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Infectious Immunology Sales Value, 2019-2030
5.5.2 South America Infectious Immunology Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Infectious Immunology Sales Value, 2019-2030
5.6.2 Middle East & Africa Infectious Immunology Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Infectious Immunology Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Infectious Immunology Sales Value
6.3 United States
6.3.1 United States Infectious Immunology Sales Value, 2019-2030
6.3.2 United States Infectious Immunology Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Infectious Immunology Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Infectious Immunology Sales Value, 2019-2030
6.4.2 Europe Infectious Immunology Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Infectious Immunology Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Infectious Immunology Sales Value, 2019-2030
6.5.2 China Infectious Immunology Sales Value by Type (%), 2023 VS 2030
6.5.3 China Infectious Immunology Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Infectious Immunology Sales Value, 2019-2030
6.6.2 Japan Infectious Immunology Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Infectious Immunology Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Infectious Immunology Sales Value, 2019-2030
6.7.2 South Korea Infectious Immunology Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Infectious Immunology Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Infectious Immunology Sales Value, 2019-2030
6.8.2 Southeast Asia Infectious Immunology Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Infectious Immunology Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Infectious Immunology Sales Value, 2019-2030
6.9.2 India Infectious Immunology Sales Value by Type (%), 2023 VS 2030
6.9.3 India Infectious Immunology Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Profile
7.1.2 Abbott Laboratories Main Business
7.1.3 Abbott Laboratories Infectious Immunology Products, Services and Solutions
7.1.4 Abbott Laboratories Infectious Immunology Revenue (US$ Million) & (2019-2024)
7.1.5 Abbott Laboratories Recent Developments
7.2 Roche Diagnostics
7.2.1 Roche Diagnostics Profile
7.2.2 Roche Diagnostics Main Business
7.2.3 Roche Diagnostics Infectious Immunology Products, Services and Solutions
7.2.4 Roche Diagnostics Infectious Immunology Revenue (US$ Million) & (2019-2024)
7.2.5 Roche Diagnostics Recent Developments
7.3 Thermo Fisher Scientifics
7.3.1 Thermo Fisher Scientifics Profile
7.3.2 Thermo Fisher Scientifics Main Business
7.3.3 Thermo Fisher Scientifics Infectious Immunology Products, Services and Solutions
7.3.4 Thermo Fisher Scientifics Infectious Immunology Revenue (US$ Million) & (2019-2024)
7.3.5 Bio-Rad Laboratories Recent Developments
7.4 Bio-Rad Laboratories
7.4.1 Bio-Rad Laboratories Profile
7.4.2 Bio-Rad Laboratories Main Business
7.4.3 Bio-Rad Laboratories Infectious Immunology Products, Services and Solutions
7.4.4 Bio-Rad Laboratories Infectious Immunology Revenue (US$ Million) & (2019-2024)
7.4.5 Bio-Rad Laboratories Recent Developments
7.5 Dr. Reddy鈥檚 Laboratories
7.5.1 Dr. Reddy鈥檚 Laboratories Profile
7.5.2 Dr. Reddy鈥檚 Laboratories Main Business
7.5.3 Dr. Reddy鈥檚 Laboratories Infectious Immunology Products, Services and Solutions
7.5.4 Dr. Reddy鈥檚 Laboratories Infectious Immunology Revenue (US$ Million) & (2019-2024)
7.5.5 Dr. Reddy鈥檚 Laboratories Recent Developments
7.6 AbbVie Inc
7.6.1 AbbVie Inc Profile
7.6.2 AbbVie Inc Main Business
7.6.3 AbbVie Inc Infectious Immunology Products, Services and Solutions
7.6.4 AbbVie Inc Infectious Immunology Revenue (US$ Million) & (2019-2024)
7.6.5 AbbVie Inc Recent Developments
7.7 Janssen Global Services
7.7.1 Janssen Global Services Profile
7.7.2 Janssen Global Services Main Business
7.7.3 Janssen Global Services Infectious Immunology Products, Services and Solutions
7.7.4 Janssen Global Services Infectious Immunology Revenue (US$ Million) & (2019-2024)
7.7.5 Janssen Global Services Recent Developments
7.8 Johnson & Johnson
7.8.1 Johnson & Johnson Profile
7.8.2 Johnson & Johnson Main Business
7.8.3 Johnson & Johnson Infectious Immunology Products, Services and Solutions
7.8.4 Johnson & Johnson Infectious Immunology Revenue (US$ Million) & (2019-2024)
7.8.5 Johnson & Johnson Recent Developments
7.9 Amgen Inc
7.9.1 Amgen Inc Profile
7.9.2 Amgen Inc Main Business
7.9.3 Amgen Inc Infectious Immunology Products, Services and Solutions
7.9.4 Amgen Inc Infectious Immunology Revenue (US$ Million) & (2019-2024)
7.9.5 Amgen Inc Recent Developments
7.10 Pfizer Inc
7.10.1 Pfizer Inc Profile
7.10.2 Pfizer Inc Main Business
7.10.3 Pfizer Inc Infectious Immunology Products, Services and Solutions
7.10.4 Pfizer Inc Infectious Immunology Revenue (US$ Million) & (2019-2024)
7.10.5 Pfizer Inc Recent Developments
7.11 Novartis
7.11.1 Novartis Profile
7.11.2 Novartis Main Business
7.11.3 Novartis Infectious Immunology Products, Services and Solutions
7.11.4 Novartis Infectious Immunology Revenue (US$ Million) & (2019-2024)
7.11.5 Novartis Recent Developments
7.12 Astellas
7.12.1 Astellas Profile
7.12.2 Astellas Main Business
7.12.3 Astellas Infectious Immunology Products, Services and Solutions
7.12.4 Astellas Infectious Immunology Revenue (US$ Million) & (2019-2024)
7.12.5 Astellas Recent Developments
7.13 Bristol-Myers Squibb Company
7.13.1 Bristol-Myers Squibb Company Profile
7.13.2 Bristol-Myers Squibb Company Main Business
7.13.3 Bristol-Myers Squibb Company Infectious Immunology Products, Services and Solutions
7.13.4 Bristol-Myers Squibb Company Infectious Immunology Revenue (US$ Million) & (2019-2024)
7.13.5 Bristol-Myers Squibb Company Recent Developments
7.14 Merck Sharp & Dohme Corp
7.14.1 Merck Sharp & Dohme Corp Profile
7.14.2 Merck Sharp & Dohme Corp Main Business
7.14.3 Merck Sharp & Dohme Corp Infectious Immunology Products, Services and Solutions
7.14.4 Merck Sharp & Dohme Corp Infectious Immunology Revenue (US$ Million) & (2019-2024)
7.14.5 Merck Sharp & Dohme Corp Recent Developments
7.15 UCB SA
7.15.1 UCB SA Profile
7.15.2 UCB SA Main Business
7.15.3 UCB SA Infectious Immunology Products, Services and Solutions
7.15.4 UCB SA Infectious Immunology Revenue (US$ Million) & (2019-2024)
7.15.5 UCB SA Recent Developments
7.16 Allergan
7.16.1 Allergan Profile
7.16.2 Allergan Main Business
7.16.3 Allergan Infectious Immunology Products, Services and Solutions
7.16.4 Allergan Infectious Immunology Revenue (US$ Million) & (2019-2024)
7.16.5 Allergan Recent Developments
8 Industry Chain Analysis
8.1 Infectious Immunology Industrial Chain
8.2 Infectious Immunology Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Infectious Immunology Sales Model
8.5.2 Sales Channel
8.5.3 Infectious Immunology Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Abbott Laboratories
Roche Diagnostics
Thermo Fisher Scientifics
Bio-Rad Laboratories
Dr. Reddy鈥檚 Laboratories
AbbVie Inc
Janssen Global Services
Johnson & Johnson
Amgen Inc
Pfizer Inc
Novartis
Astellas
Bristol-Myers Squibb Company
Merck Sharp & Dohme Corp
UCB SA
Allergan

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.